About Jonathan Stauber
Born entrepreneur he has created ImaBiotech in 2009 to provide a new tool to better assess drug efficacy.
As such, he has acquired an extensive knowledge of imaging markets for preclinical and clinical applications but also in human capital management. Dr. Stauber received a Ph.D. in Proteomics and molecular biology from the University of California (San Diego, USA) and the University of Technology of Lille (France), and a Post-Doc to integrate multimodal imaging platform with MSI and MRI techniques in AMOLF (Amsterdam, The Netherlands).
He worked and published more than 30 papers and book chapters on the development and applications of Mass Spectrometry Imaging (MSI).